Intermediate for Apixaban. Apixaban (trade name: Eliquis) is a direct factor Xa inhibitor for the treatment of venous thromboembolic events. Apixaban has been approved by the U.S Food and Drug Administration on March 18, 2014.
Product Name: 5-Chloro-N-(4-nitrophenyl)pentanamide
CAS Number: 1039914-85-6
Molecular Weight:  256.6883
Molecular Formula:  C11H13ClN2O3
Purity (HPLC): ≥95%
Shipping Conditions: Room temperature.
Storage Conditions: Refrigerated.
Regulatory Statement:  For Research Use Only.